Robotic-assisted interval cytoreductive surgery in ovarian cancer: a feasibility study

키워드

참고문헌 (31)

1. Siegel RL, "Cancer statistics, 2019", CA Cancer J Clin, 69, pp.7~34 (2019)
2. Vergote I, "Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer", N Engl J Med, 363, pp.943~953 (2010)
3. Kehoe S, "Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer(CHORUS) : an open-label, randomised, controlled, noninferiority trial", Lancet, 386, pp.249~257 (2015)
4. Onda T, "Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III", IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial : Japan Clinical Oncology Group Study JCOG0602, 2016, pp.64, 22~31
5. Vergote I, "Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers : pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials", Lancet Oncol, 19, pp.1680~1687 (2018)
6. Wright AA, "Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer : Society of Gynecologic Oncology and American Society of Clinical Oncology clinical practice guideline", J Clin Oncol, 34, pp.3460~3473 (2016)
7. Chang SJ, "Evolution of surgical treatment paradigms for advanced-stage ovarian cancer : redefining ‘optimal’residual disease", Gynecol Oncol, 125, pp.483~492 (2012)
8. Hamilton CA, "Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer : an NRG Oncology", Gynecologic Oncology Group ancillary data study, 2018, pp.148, 275~280
9. Schorge JO, "Meigs to modern times : the evolution of debulking surgery in advanced ovarian cancer", Gynecol Oncol, 149, pp.447~454 (2018)
10. Fagotti A, "Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load(SCORPION trial) : final analysis of perioperative outcome", Eur J Cancer, 59, pp.22~33 (2016)
11. Melamed A, "Laparoscopy compared with laparotomy for debulking ovarian cancer after neoadjuvant chemotherapy", Obstet Gynecol, 129, pp.861~869 (2017)
12. Gueli Alletti S, "Minimally invasive interval debulking surgery in ovarian neoplasm(MISSION trial-NCT02324595) : a feasibility study", Am J Obstet Gynecol, 214, pp.503.e1~503.e6 (2016)
13. "National Comprehensive Cancer Network’s practice guidelines in oncology. Ovarian cancer" (2018)[URL]
14. Ergina PL, "Challenges in evaluating surgical innovation", Lancet, 374, pp.1097~1104 (2009)
15. Garas G, "Network analysis of surgical innovation : measuring value and the virality of diffusion in robotic surgery", PLoS One, 12, pp.e0183332~ (2017)
16. Rutten MJ, "Laparoscopy to predict the result of primary cytoreductive surgery in patients with advanced ovarian cancer : a randomized controlled trial", J Clin Oncol, 35, pp.613~621 (2017)
17. Böhm S, "Chemotherapy response score : development and validation of a system to quantify histopathologic response to neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma", J Clin Oncol, 33, pp.2457~2463 (2015)
18. Nelson G, "Guidelines for pre-and intra-operative care in gynecologic", oncology surgery : Enhanced Recovery After Surgery(ERAS®)Society recommendations--part I, 2016, pp.140, 313~322
19. Nelson G, "Guidelines for postoperative care in gynecologic", oncology surgery : Enhanced Recovery After Surgery(ERAS®)Society recommendations--part II, 2016, pp.140, 323~332
20. Aletti GD, "A new frontier for quality of care in gynecologic oncology surgery : multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model", Gynecol Oncol, 107, pp.99~106 (2007)
21. Lucidi A, "Role of robotic surgery in ovarian malignancy", Best Pract Res Clin Obstet Gynaecol, 45, pp.74~82 (2017)
22. Magrina JF, "Robotic approach for ovarian cancer : perioperative and survival results and comparison with laparoscopy and laparotomy", Gynecol Oncol, 121, pp.100~105 (2011)
23. Nezhat FR, "Comparison of perioperative outcomes and complication rates between conventional versus robotic-assisted laparoscopy in the evaluation and management of early, advanced, and recurrent stage ovarian, fallopian tube, and primary peritoneal cancer", Int J Gynecol Cancer, 24, pp.600~607 (2014)
24. Feuer GA, "Perioperative and clinical outcomes in the management of epithelial ovarian cancer using a robotic or abdominal approach", Gynecol Oncol, 131, pp.520~524 (2013)
25. Ackroyd SA, "Interval robotic cytoreduction following neoadjuvant chemotherapy in advanced ovarian cancer", J Robot Surg, 12, pp.245~250 (2018)
26. Tozzi R, "Interval laparoscopic en-bloc resection of the pelvis(L-EnBRP)in patients with stage IIIC-IV ovarian cancer : description of the technique and surgical outcomes", Gynecol Oncol, 142, pp.477~483 (2016)
27. Favero G, "Oncologic concerns regarding laparoscopic cytoreductive surgery in patients with advanced ovarian cancer submitted to neoadjuvant chemotherapy", Oncology, 89, pp.159~166 (2015)
28. Corrado G, "Laparoscopic debulking surgery in the management of advanced ovarian cancer after neoadjuvant chemotherapy", Int J Gynecol Cancer, 25, pp.1253~1257 (2015)
29. Cardenas-Goicoechea J, "Minimally invasive interval cytoreductive surgery in ovarian cancer : systematic review and meta-analysis", J Robot Surg, 13, pp.23~33 (2019)
30. Brown J, "When less is more : minimally invasive surgery compared with laparotomy for interval debulking after neoadjuvant chemotherapy in women with advanced ovarian cancer", J Minim Invasive Gynecol, 26, pp.902~909 (2019)
31. Fagotti A, "The INTERNATIONAL MISSION study : minimally invasive surgery in ovarian neoplasms after neoadjuvant chemotherapy", Int J Gynecol Cancer, 29, pp.5~9 (2019)

관련 논문AI추천